These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 32925514)

  • 1. Substance Use Disorders in Global Mental Health Delivery: Epidemiology, Treatment Gap, and Implementation of Evidence-Based Treatments.
    Connery HS; McHugh RK; Reilly M; Shin S; Greenfield SF
    Harv Rev Psychiatry; 2020; 28(5):316-327. PubMed ID: 32925514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges and Opportunities in Global Mental Health: a Research-to-Practice Perspective.
    Wainberg ML; Scorza P; Shultz JM; Helpman L; Mootz JJ; Johnson KA; Neria Y; Bradford JE; Oquendo MA; Arbuckle MR
    Curr Psychiatry Rep; 2017 May; 19(5):28. PubMed ID: 28425023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance use disorder approaches in US primary care clinics with national reputations as workforce innovators.
    O'Malley DM; Abraham CM; Lee HS; Rubinstein EB; Howard J; Hudson SV; Kieber-Emmons AM; Crabtree BF
    Fam Pract; 2022 Mar; 39(2):282-291. PubMed ID: 34423366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Closing the mental health gap in low-income settings by building research capacity: perspectives from Mozambique.
    Sweetland AC; Oquendo MA; Sidat M; Santos PF; Vermund SH; Duarte CS; Arbuckle M; Wainberg ML
    Ann Glob Health; 2014; 80(2):126-33. PubMed ID: 24976551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.
    Hennessy EA; Tanner-Smith EE; Finch AJ; Sathe N; Kugley S
    Campbell Syst Rev; 2018; 14(1):1-86. PubMed ID: 37131375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening and management of mental health and substance use disorders in HIV treatment settings in low- and middle-income countries within the global IeDEA consortium.
    Parcesepe AM; Mugglin C; Nalugoda F; Bernard C; Yunihastuti E; Althoff K; Jaquet A; Haas AD; Duda SN; Wester CW; Nash D;
    J Int AIDS Soc; 2018 Mar; 21(3):e25101. PubMed ID: 29603887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community-based psychosocial substance use disorder interventions in low-and-middle-income countries: a narrative literature review.
    Heijdra Suasnabar JM; Hipple Walters B
    Int J Ment Health Syst; 2020; 14():74. PubMed ID: 33062049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-national patterns of substance use disorder treatment and associations with mental disorder comorbidity in the WHO World Mental Health Surveys.
    Harris MG; Bharat C; Glantz MD; Sampson NA; Al-Hamzawi A; Alonso J; Bruffaerts R; Caldas de Almeida JM; Cia AH; de Girolamo G; Florescu S; Gureje O; Haro JM; Hinkov H; Karam EG; Karam G; Lee S; Lépine JP; Levinson D; Makanjuola V; McGrath J; Mneimneh Z; Navarro-Mateu F; Piazza M; Posada-Villa J; Rapsey C; Tachimori H; Ten Have M; Torres Y; Viana MC; Chatterji S; Zaslavsky AM; Kessler RC; Degenhardt L;
    Addiction; 2019 Aug; 114(8):1446-1459. PubMed ID: 30835879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peer-delivered services for substance use in low- and middle-income countries: A systematic review.
    Satinsky EN; Kleinman MB; Tralka HM; Jack HE; Myers B; Magidson JF
    Int J Drug Policy; 2021 Sep; 95():103252. PubMed ID: 33892281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptability and feasibility of using non-specialist health workers to deliver mental health care: stakeholder perceptions from the PRIME district sites in Ethiopia, India, Nepal, South Africa, and Uganda.
    Mendenhall E; De Silva MJ; Hanlon C; Petersen I; Shidhaye R; Jordans M; Luitel N; Ssebunnya J; Fekadu A; Patel V; Tomlinson M; Lund C
    Soc Sci Med; 2014 Oct; 118():33-42. PubMed ID: 25089962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities, 3rd edition.
    Patel V; Chisholm D; Parikh R; Charlson FJ; Degenhardt L; Dua T; Ferrari AJ; Hyman S; Laxminarayan R; Levin C; Lund C; Medina Mora ME; Petersen I; Scott J; Shidhaye R; Vijayakumar L; Thornicroft G; Whiteford H;
    Lancet; 2016 Apr; 387(10028):1672-85. PubMed ID: 26454360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A legal dispute resolution intervention for patients with substance use disorders: a study protocol for a randomized controlled trial.
    O'Neil MM; Johnson RA; Córdova D; Pryor J; Pinals DA
    BMC Public Health; 2023 Mar; 23(1):435. PubMed ID: 36879259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Social workers and delivery of evidence-based psychosocial treatments for substance use disorders.
    Wells EA; Kristman-Valente AN; Peavy KM; Jackson TR
    Soc Work Public Health; 2013; 28(3-4):279-301. PubMed ID: 23731420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutual Capacity Building to Reduce the Behavioral Health Treatment Gap Globally.
    Jack HE; Myers B; Regenauer KS; Magidson JF
    Adm Policy Ment Health; 2020 Jul; 47(4):497-500. PubMed ID: 31823100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High inpatient utilization among Veterans Health Administration patients with substance-use disorders and co-occurring mental health conditions.
    Painter JM; Malte CA; Rubinsky AD; Campellone TR; Gilmore AK; Baer JS; Hawkins EJ
    Am J Drug Alcohol Abuse; 2018; 44(3):386-394. PubMed ID: 29095057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of Mental Health Service Utilization and High Mental Health Service Use Among Women Eight Years After Initiating Substance Use Disorder Treatment.
    Evans E; Padwa H; Li L; Lin V; Hser YI
    J Subst Abuse Treat; 2015 Dec; 59():10-9. PubMed ID: 26321439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients admitted to treatment for substance use disorder in Norway: a population-based case-control study of socio-demographic correlates and comparative analyses across substance use disorders.
    Amundsen EJ; Bretteville-Jensen AL; Rossow I
    BMC Public Health; 2022 Apr; 22(1):792. PubMed ID: 35443672
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.